-
2023-506518-33-00
5
2021-11-10
Locally Advanced or Metastatic Non-Small Cell Lung Cancer
-
2023-507698-16-00
5
2021-10-14
Chronic Lymphocytic Leukemia/Small
Lymphocytic Lymphoma (BRUIN CLL-322
-
2024-516651-41-00
5
2021-10-08
COPD : chronic obstructive Pulmonary disease
-
2023-507494-18-00
5
2021-09-24
Non-small cell lung cancer with ROS proto-oncogene 1, receptor tyrosin
-
2023-506270-13-00
4
2021-07-27
Relapsed/refractory diffuse large B cell lymphoma (R-R DLBCL)
-
2023-508372-10-00
4
2021-05-19
Non small Cell Lung cancer
-
2024-511052-41-00
5
2021-05-10
Autoimmune Pulmonary Alveolar Proteinosis
-
2024-511658-28-01
5
2021-04-06
primary sclerosing cholangitis
-
2023-506526-37-00
5
2021-03-17
Paroxysmal Nocturnal Hemoglobinuria (PNH)
-
2024-513659-34-00
9
2021-02-12
Relapsed/Refractory aggressive B-NHL
-
2024-512238-13-00
4
2021-02-10
Metastatic or Locally Advanced EGFR mutated Non-Small Cell Lung Cancer
-
2024-513325-23-00
4
2021-02-03
Myelofibrosis
-
2023-507338-26-00
5
2021-02-01
Histologically documented gastric or gastroesophageal junction adenoca
-
2024-513252-15-00
4
2021-01-28
IN RELAPSED/REFRACTORY PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA
-
2023-507475-21-00
10
2021-01-18
Lung Cancer, Non-Small Cell
-
2023-509358-72-00
5
2020-11-23
Diffuse large B-cell lymphoma
-
2023-503380-42-00
6
2020-11-16
patient with moderate to severe Crohn's disease
with at least one acti
-
2023-504998-20-00
5
2020-09-18
Metastatic Hormone-sensitive Prostate Cancer Characterised by PTEN def
-
2023-507062-34-00
7
2020-08-07
High-Risk large B-Cell lymphoma
-
2024-516102-36-00
4
2020-07-29
Minimal Change Nephrotic Syndrom
-
2023-507236-20-00
9
2020-07-28
Follicular Lymphoma (FL)
-
2023-507419-37-00
5
2020-06-25
Plasma cell myeloma
-
2023-508214-42-00
5
2020-05-25
Previously treated locally advanced and unresectable or metastatic
non
-
2023-510537-28-00
5
2020-05-15
Multiple Myeloma